| 000 | 01388 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513060347.0 | ||
| 264 | 0 | _c19940929 | |
| 008 | 199409s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00684865 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchacter, L P | |
| 245 | 0 | 0 |
_aClinical and pharmacokinetic overview of parenteral etoposide phosphate. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1994 |
||
| 300 |
_aS58-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xadministration & dosage |
| 700 | 1 | _aIgwemezie, L N | |
| 700 | 1 | _aSeyedsadr, M | |
| 700 | 1 | _aMorgenthien, E | |
| 700 | 1 | _aRandolph, J | |
| 700 | 1 | _aAlbert, E | |
| 700 | 1 | _aSantabárbara, P | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 34 Suppl _gp. S58-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00684865 _zAvailable from publisher's website |
| 999 |
_c8069355 _d8069355 |
||